about
Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal systemAnthranilate fluorescence marks a calcium-propagated necrotic wave that promotes organismal death in C. elegansSIRT2 as a Therapeutic Target for Age-Related DisordersPretreatment with apoaequorin protects hippocampal CA1 neurons from oxygen-glucose deprivationSuccessful cognitive and emotional agingProtein phosphatase 5 protects neurons against amyloid-beta toxicitySpatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) depositionThe neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodiesClinical and morphological determinants of focal neurological deficits in patients with unruptured brain arteriovenous malformationGlutamate and neurotrophic factors in neuronal plasticity and diseaseThe Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain"Changes in Regenerative Capacity through LifespanThe Incremental Induction of Neuroprotective Properties by Multiple Therapeutic Strategies for Primary and Secondary Neural InjuryMicroglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In VivoNucleolar activity in neurodegenerative diseases: a missing piece of the puzzle?Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs)Impact of age-related neuroglial cell responses on hippocampal deteriorationSIRT1 and SIRT2: emerging targets in neurodegenerationMetabolomics of human brain aging and age-related neurodegenerative diseasesSchisandrin B as a hormetic agent for preventing age-related neurodegenerative diseasesTherapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic reviewβ2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesisA PARP1-ERK2 synergism is required for the induction of LTPDynamin-related protein 1 is required for normal mitochondrial bioenergetic and synaptic function in CA1 hippocampal neurons.A loss of FUS/TLS function leads to impaired cellular proliferationImproved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetamNon-Viral Nucleic Acid Delivery Strategies to the Central Nervous SystemPreventing Alzheimer's disease by means of natural selectionThe Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNSCellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disordersNAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicityAgeing increases vulnerability to aβ42 toxicity in DrosophilaMechanisms of sensorineural cell damage, death and survival in the cochlea.Resting state functional connectivity in preclinical Alzheimer's diseaseA neuroprotective phase precedes striatal degeneration upon nucleolar stress.Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.The progeroid gene BubR1 regulates axon myelination and motor function.Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.Structural imaging measures of brain aging.
P2860
Q21090220-294E49B9-3900-45E1-815C-418941451977Q21092703-91D48B6D-511A-4B35-B61E-C6B2330640E6Q21129286-72EEEF52-5B80-44C9-A27E-AE0D5E45F68CQ21132442-10EEC0A0-2E7F-4377-8534-19FAC1506D0DQ24601183-03AB34D0-85D4-4821-9BD0-3CA7CB6B7837Q24615285-7E2080C8-59D2-4AF6-98A9-1A602656A69EQ24631814-D9798D08-FA63-44F5-9F13-3FFA3B6839BFQ24646616-48FDB306-0A0A-4E0A-A705-3646B3BDE13EQ24650299-32383FFF-925F-4C45-8E73-A450D2BC6FB6Q24653626-1CFE8649-EDE0-4426-95B9-21408DC53306Q26743578-2174FF71-B2B3-491D-A9FE-2B3A49448959Q26778013-33209247-E004-439B-8FC7-747C81815DF5Q26795755-20D814B4-760E-4EE0-B13D-9F95544EE739Q26798185-E0988F75-57F3-4D13-B35E-B21CB58DFE6DQ26821979-67324FD6-09A3-44E4-A4D7-F0DA70851D28Q26823798-9A6D5BE8-FB4B-4369-B078-327D35BC4801Q26825419-677B97DA-563B-4EC3-84F5-1F41174FA1F7Q26864929-E6A7D1A0-F5CC-4791-A5AF-191812BB731FQ26992344-05A9D0D5-AD49-4E92-A9C0-ABB7468E7A67Q27002536-4FA97541-EEFE-4865-8FC1-4BE4E3A91B2CQ27008479-93091051-8F36-476E-9862-F55F56CB15B2Q27315300-19857653-00C0-4FEB-80D3-AE87BC9C0894Q27318920-6015D71B-BE08-48B2-A755-C3ED07E7076DQ27329184-CCD72E9D-9BBF-4B23-A315-CF0DF44F942AQ27331026-3B62CB52-9635-4A80-B6F0-236281742F42Q27500402-0C6E5DCA-CD56-45C7-A7BB-E74C07F02E68Q28068242-B5BFF228-1D49-4714-B870-EE0CDCB1D3FBQ28088701-FEFDBD49-8AC9-4F83-A961-BEEBC3C30CB1Q28244138-6B19325E-2909-4393-9C33-C6EE78F18DD4Q28384232-2BE9F894-A70C-4334-A402-C2E4D870F0E4Q28476267-46AE8F9A-13AB-4C85-B700-025E65C7ED28Q28727201-BC84DED1-2990-45D6-AA3E-D2C8376F1F16Q30412447-50AC3297-D74A-49FE-84FB-B50679AAE911Q30531401-DAB09D15-AE19-496C-9533-68B58B975F17Q30549660-F1ABBDE6-F63A-4E12-8918-49F63098B9F3Q30597164-49953849-0561-4E24-B7D3-59CB62C5F687Q30658867-29C584D4-77F1-4A4C-A66A-7D2686BEEE8FQ30833258-367147AF-4C53-4D5F-97F1-5CB3D3E85088Q30835713-8E7C4D58-2A93-406A-9553-DA89C36450CCQ30844186-578845FD-D3A1-40A2-95C0-8954BB517313
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Ageing and neuronal vulnerability.
@ast
Ageing and neuronal vulnerability.
@en
type
label
Ageing and neuronal vulnerability.
@ast
Ageing and neuronal vulnerability.
@en
prefLabel
Ageing and neuronal vulnerability.
@ast
Ageing and neuronal vulnerability.
@en
P2860
P356
P1476
Ageing and neuronal vulnerability.
@en
P2093
Mark P Mattson
Tim Magnus
P2860
P2888
P304
P356
10.1038/NRN1886
P407
P577
2006-04-01T00:00:00Z